Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C

Neuropsychopharmacology

Volumn 37, Issue 2, 2012, Pages 543-556

  Nimitvilai, Sudarat ^a   Arora, Devinder S ^a   Brodie, Mark S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

D2 receptor; D5 receptor; desensitization; dopamine; protein kinase C; ventral tegmental area

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 8 BROMO CYCLIC AMP; CHELERYTHRINE; COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 2 RECEPTOR; FORSKOLIN; NIFEDIPINE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN KINASE C BETA INHIBITOR; QUINPIROLE; RYANODINE; THAPSIGARGIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC NERVE CELL; EXTRACELLULAR CALCIUM; INFORMATION PROCESSING; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REINFORCEMENT; VENTRAL TEGMENTUM;

ACTION POTENTIALS; AGE FACTORS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME ACTIVATION; MICROINJECTIONS; NEURAL INHIBITION; PROTEIN KINASE C; RATS; RATS, INBRED F344; TYPE C PHOSPHOLIPASES; VENTRAL TEGMENTAL AREA;

EID: 84856036652     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.222     Document Type: Article

References (65)

1. Akita Y, Ohno S, Konno Y, Yano A, Suzuki K (1990). Expression and properties of two distinct classes of the phorbol ester receptor family, four conventional protein kinase C types, and a novel protein kinase C. J Biol Chem 265: 354-362.
2. Bian JH, Ghosh TK, Wang JC, Gill DL (1991). Identification of intracellular calcium pools. Selective modification by thapsigargin. J Biol Chem 266: 8801-8806. (Pubitemid 21906586)
3. Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, Nanoff C (2000). Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 275: 32672-32680.
4. Brewer LD, Thibault O, Staton J, Thibault V, Rogers JT, Garcia-Ramos G et al (2007). Increased vulnerability of hippocampal neurons with age in culture: temporal association with increases in NMDA receptor current, NR2A subunit expression and recruitment of L-type calcium channels. Brain Res 1151: 20-31. (Pubitemid 46709872)
5. Brodie MS, Dunwiddie TV (1990). Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch Pharmacol 342: 660-665.
6. Brodie MS, McElvain MA, Bunney EB, Appel SB (1999a). Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons. J Pharmacol Exp Ther 290: 325-333. (Pubitemid 29302339)
7. Brodie MS, Pesold C, Appel SB (1999b). Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exper Res 23: 1848-1852.
8. Buck E, Zimanyi I, Abramson JJ, Pessah IN (1992). Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J Biol Chem 267: 23560-23567. (Pubitemid 23088155)
9. Caille I, Dumartin B, Bloch B (1996). Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730: 17-31. (Pubitemid 26305320)
10. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M et al (2000). Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37: 125-145. (Pubitemid 30447944)
11. Cragg S, Rice ME, Greenfield SA (1997). Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J Neurophysiol 77: 863-873. (Pubitemid 27087785)
12. Defagot MC, Malchiodi EL, Villar MJ, Antonelli MC (1997). Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res 45: 1-12. (Pubitemid 27182219)
13. Deng C, Li KY, Zhou C, Ye JH (2009). Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area. Neuropsychopharmacology 34: 1233-1244.
14. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic dopamine system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
15. Gao C, Wolf ME (2008). Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem 106: 2489-2501.
16. George SR, O'Dowd BF (2007). A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. Scient World J 7: 58-63.
17. Grace AA, Bunney BS (1984). The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4: 2866-2876. (Pubitemid 15224431)
18. Grisshammer R, Hermans E (2001). Functional coupling with Galpha(q) and Galpha(i1) protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli. FEBS Lett 493: 101-105. (Pubitemid 32245785)
19. Guerreiro S, Marien M, Michel PP (2011). Methylxanthines and ryanodine receptor channels. Handb Exp Pharmacol 200: 135-150.
20. Hashimoto T, Ase K, Sawamura S, Kikkawa U, Saito N, Tanaka C et al (1988). Postnatal development of a brain-specific subspecies of protein kinase C in rat. J Neurosci 8: 1678-1683.
21. Hill ER, Tian J, Tilley MR, Zhu MX, Gu HH (2009). Potencies of cocaine methiodide on major cocaine targets in mice. PLoS One 4: e7578.
22. Imperato A, Di Chiara G (1986). Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239: 219-228. (Pubitemid 16006360)
23. Imperato A, Mulas A, Di Chiara G (1986). Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132: 337-338. (Pubitemid 17003483)
24. Jiang D, Sibley DR (1999). Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization. Mol Pharmacol 56: 675-683. (Pubitemid 29491168)
25. Kenakin TP (1987). Analysis of dose-response data. In: Pharmacologic Analysis of Drug-Rreceptor Interaction. Kenakin TP (ed). Raven Press: New York, NY. pp 129-162.
26. Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, de la CA (2000). Dopamine D5 receptors of rat and human brain. Neuroscience 100: 689-699.
27. Kim KM, Nakajima Y, Nakajima S (1995). G proteincoupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons. Neuroscience 69: 1145-1158.
28. Lacey MG, Mercuri NB, North RA (1987). Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (Lond) 392: 397-416. (Pubitemid 18014315)
29. Lacey MG, Mercuri NB, North RA (1989). Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci 9: 1233-1241. (Pubitemid 19116743)
30. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J (2008). Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773. (Pubitemid 351335346)
31. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ et al (2004). Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279: 35671-35678. (Pubitemid 39100570)
32. 2 receptors and protein kinase C. J Neurophysiol 90: 3201-3212. (Pubitemid 37430016)
33. Luu P, Malenka RC (2008). Spike timing-dependent long-term potentiation in ventral tegmental area dopamine cells requires PKC. J Neurophysiol 100: 533-538.
34. Margolis EB, Lock H, Hjelmstad GO, Fields HL (2006). The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol 577: 907-924. (Pubitemid 44873655)
35. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL (2008). Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci 28: 8908-8913.
36. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H et al (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197. (Pubitemid 23145960)
37. McDonald BJ, Chung HJ, Huganir RL (2001). Identification of protein kinase C phosphorylation sites within the AMPA receptor GluR2 subunit. Neuropharmacology 41: 672-679. (Pubitemid 32972184)
38. 2+ stores in neurons. Identification and functional aspects. J Physiol Paris 86: 23-30. (Pubitemid 23061470)
39. Minami H, Owada Y, Suzuki R, Handa Y, Kondo H (2000). Localization of mRNAs for novel, atypical as well as conventional protein kinase C (PKC) isoforms in the brain of developing and mature rats. J Mol Neurosci 15: 121-135. (Pubitemid 32108681)
40. Mirenowicz J, Schultz W (1996). Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379: 449-451. (Pubitemid 26039524)
41. Morikawa H, Imani F, Khodakhah K, Williams JT (2000). Inositol 1,4,5-triphosphate-evoked responses in midbrain dopamine neurons. J Neurosci 20: RC103.
42. Mueller AL, Brodie MS (1989). Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation. J Neurosci Methods 28: 15-22. (Pubitemid 19110207)
43. Nabekura J, Omura T, Horimoto N, Ogawa T, Akaike N (1996). Alpha 1 adrenoceptor activation potentiates taurine response mediated by protein kinase C in substantia nigra neurons. J Neurophysiol 76: 2455-2460. (Pubitemid 26346420)
44. Namkung Y, Sibley DR (2004). Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem 279: 49533-49541. (Pubitemid 39625841)
45. Nimitvilai S, Brodie MS (2010). Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther 333: 555-563.
46. Nishizuka Y (2001). The protein kinase C family and lipid mediators for transmembrane signaling and cell regulation. Alcohol Clin Exp Res 25: 3S-7S.
47. Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD et al (2003). 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34: 97-108. (Pubitemid 36790448)
48. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R et al (2007). D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104: 654-659. (Pubitemid 46123080)
49. Saal D, Dong Y, Bonci A, Malenka RC (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577-582. (Pubitemid 36262980)
50. Sah P, Francis K, McLachlan EM, Junankar P (1993). Distribution of ryanodine receptor-like immunoreactivity in mammalian central nervous system is consistent with its role in calciuminduced calcium release. Neuroscience 54: 157-165. (Pubitemid 23147096)
51. Schultz W (2010). Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 6: 24.
52. Sesack SR, Aoki C, Pickel VM (1994). Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14: 88-106.
53. So CH, Varghese G, Curley KJ, Kong MM, Alijaniaram M, Ji X et al (2005). D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol 68: 568-578. (Pubitemid 41206010)
54. So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O'Dowd BF et al (2009). Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor heterooligomers. Mol Pharmacol 75: 843-854.
55. Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P (2000). Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther 295: 1223-1231.
56. Sulzer D (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69: 628-649.
57. Sun X, Milovanovic M, Zhao Y, Wolf ME (2008). Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. J Neurosci 28: 4216-4230.
58. Sutko JL, Airey JA, Welch W, Ruest L (1997). The pharmacology of ryanodine and related compounds. Pharmacol Rev 49: 53-98. (Pubitemid 27142417)
59. Thibault D, Albert PR, Pineyro G, Trudeau LE (2011). Neurotensin triggers dopamine D2 receptor desensitiz. J Biol Chem 286: 9174-9184.
60. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M et al (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781. (Pubitemid 21907725)
61. 2+)-ATPases. Trends Pharmacol Sci 19: 131-135. (Pubitemid 28218535)
62. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411: 583-587. (Pubitemid 32531404)
63. Wise RA (1996). Neurobiology of addiction. Curr Opin Neurobiol 6: 243-251. (Pubitemid 26168484)
64. Yoshida Y, Huang FL, Nakabayashi H, Huang KP (1988). Tissue distribution and developmental expression of protein kinase C isozymes. J Biol Chem 263: 9868-9873.
65. 2+ release channel from skeletal muscle sarcoplasmic reticulum. Mol Pharmacol 42: 1049-1057. (Pubitemid 23028842)